Antonio Portarapillo

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Hidradenitis Suppurativa

Top Venues

Clinical, cosmetic and investigational dermatology

Psoriasis (Auckland, N.Z.)

Clinical and experimental dermatology

Pediatric health, medicine and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Fabrizio Martora, Teresa Battista, Luca Potestio, Antonio Portarapillo, Nello Tommasino, Matteo Megna
Long-Term Efficacy of Guselkumab in an Adolescent Hidradenitis Suppurativa Patients: A Case Report. Clinical, cosmetic and investigational dermatology 17 (2024)
Fabrizio Martora, Teresa Battista, Luca Potestio, Antonio Portarapillo, Nello Tommasino, Matteo Megna
Long-Term Efficacy of Guselkumab in an Adolescent Hidradenitis Suppurativa Patients: A Case Report. Clinical, cosmetic and investigational dermatology 17 (2024)
Luca Potestio, Giuseppe Lauletta, Nello Tommasino, Antonio Portarapillo, Antonia Salsano, Teresa Battista, Fabrizio Martora, Matteo Megna
Risk Factors for Psoriasis Flares: A Narrative Review. Psoriasis (Auckland, N.Z.) 14 (2024)
Antonio Portarapillo, Valeria Esposito, Matteo Megna, Luca Potestio, Rosita Comune, Fabrizio Martora, Ruggiero Angelo
The role of teledermatology for the long-term management of stable psoriasis treated with biologics: a survey-based study. Clinical and experimental dermatology (2024)
Luca Potestio, Giuseppe Lauletta, Nello Tommasino, Antonio Portarapillo, Antonia Salsano, Teresa Battista, Fabrizio Martora, Matteo Megna
Risk Factors for Psoriasis Flares: A Narrative Review. Psoriasis (Auckland, N.Z.) 14 (2024)
Matteo Megna, Ruggiero Angelo, Antonia Salsano, Giuseppe Lauletta, Antonio Portarapillo, Ginevra Torta, Fabrizio Martora, Luca Potestio
A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab. Clinical, cosmetic and investigational dermatology 16 (2023)
Ruggiero Angelo, Antonio Portarapillo, Matteo Megna, Cataldo Patruno, Maddalena Napolitano
Management Strategies for Pediatric Moderate-to-Severe Plaque Psoriasis: Spotlight on Biologics. Pediatric health, medicine and therapeutics 14 (2023)